Researchers continue to excited about the medication , a novel dual agonist showing remarkable results in early trials for weight management. It functions by targeting two hormones : GLP-1 and GIP, which , https://dianealsg623461.blogs-service.com/71883231/a-new-possibility-for-size-reduction